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Abstract 
 
Patient safety is a global concern and is the most important domains of health-care quality. Medical error is a major 
patient safety concern, causing increase in health-care cost due to mortality, morbidity, or prolonged hospital stay. A 
definition for patient safety has emerged from the health care quality movement that is equally abstract, with various 
approaches to the more concrete essential components. Patient safety was defined by the IOM as “the prevention of 
harm to patients.” Emphasis is placed on the system of care delivery that prevents errors; learns from the errors that 
do occur; and is built on a culture of safety that involves health care professionals, organizations, and patients. 
Patient safety culture is a complex phenomenon. Patient safety culture assessments, required by international 
accreditation organizations, allow healthcare organizations to obtain a clear view of the patient safety aspects 
requiring urgent attention, identify the strengths and weaknesses of their safety culture, help care giving units 
identify their existing patient safety problems, and benchmark their scores with other hospitals.  
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Introduction 
Since patient safety was first brought to light in the 
1990s, studies have shown a staggering number of 
patients harmed by preventable medical errors. These 
errors include systems failures, human factors, 
complicated technologies, powerful drugs, prolonged 
hospital stays, and cost-cutting measures, to name a 
few. Medical errors can cause serious injury or death 
and result in billions of dollars in excess health care 
costs nationwide each year. WHO estimates that one 
out of every 10 patients worldwide are impacted by 
these errors. Death may not quite be the final cure for 
life’s ills that Socrates imagined. Recent safety issues 
imposed by healthcare providers are merely medication 
safety, provider patient ratio, length of physician 
consultation, medical supply shortages, quality 
reporting, antibiotic resistance, sepsis, unnecessary 
emergency hospitalizations, poor diagnosis, wrong 
prescribing and treatment etc.  
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A good health system aims to deliver the best possible 
care to the individual patient while at the same time 
being responsive to the health needs of the entire 
population it serves. For many health systems 
worldwide, resources are an important limitation. 
Commercialism and profit orientation in medicine are 
an important cost driver. Similar controversies exist 
with regard to improvements in quality and fairness of 
healthcare delivery. It is increasingly hard to find areas 
of life into which commercialism has not encroached. 
The corrosive effects of advertising and 
commercialization are more damaging because of the 
ways modern societies have come to rely on 
physicians, and are often made less healthy in the 
process. Here it is important to remember that 
commercial forces not only respond to markets, but 
work diligently to create markets. A prime example is 
pharmaceutical advertising to the public. Drug 
advertisements influence patients to ask their 
physicians about drugs that have been promoted. 
 
Commercialism in Healthcare Service 
Healthcare Commercialism is defined by the IHC 
Forum as, “transforming an employer's health benefit 
plan into one that puts economic purchasing power—
and decision-making—in the hands of participants. 
This is best achieved by supplying employees with the 
decision-making information and support tools they 
International Journal of Health and Clinical Research, 2018;1(2):14-26                e-ISSN: 2590-3241, p-ISSN: 2590-325X                         
                                                             
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________ 
Mohiuddin                    International Journal of Health and Clinical Research, 2018; 1(2):14-26 
www.ijhcr.com                              
        15 
 
need, along with financial incentives, rewards, and 
other benefits that encourage personal involvement in 
altering health and health care purchasing behaviors. 
Commercialism in health care is an application of 
operating and managing principles typically found in 
business and commerce (financial incentivizing, 
profit‐making, competition, marketing/advertising, and 
focus on the bottom line) to health care delivery. The 
US health care system ranks the highest on 
commercialism among Western industrialized 
democracies. Commercialism poses a threat to medical 
professionalism, patient care, and even the integrity of 
science, which is a foundation of our trust in medicine 
and medical professionalism. This is a timely topic that 
is getting some attention in the bioethics and medical 
literature. The idea of the profit motive in healthcare 
and the impact that it has on the professional practice 
of nurses and physicians should be thoroughly judged. 
The public healthcare systems have always had various 
weaknesses, which the capitalist media have 
relentlessly exploited. A private healthcare sector is 
nearly always active alongside the public system, 
providing parallel provision for those who can pay, 
cherry-picking profitable services, offering ‘hotel’ style 
hospital accommodation, short waiting times for 
treatment – i.e. in general offering a model of a 
commodified service that looks attractive precisely 
because it is expensive. But the most important 
common factor in the success of capital’s drive to 
convert state-funded health care into a profit-making 
commodity has undoubtedly been the wider hegemony 
of neoliberalism, both as a system of social practices 
and as a system of ideas. In Germany for example, 
private hospitals treat patients who are older on 
average and who have more serious health conditions   
than those in public hospitals.  The data also show   
that   private   for-profit   hospitals   are   better-
equipped to treat difficult cases and more complex 
pathologies.  Moreover, a larger proportion of beds in 
these hospitals are reserved for emergency room and 
intensive care patients [1-5]. 
 
Medication Safety 
Close to 6,800 prescription medications and countless 
over-the-counter drugs are available in the United 
States.It is estimated that in 2019, 4.25 billion retail 
prescriptions will be filled throughout the United States 
[6]. To further complicate a practitioner's responsibility 
during patient care, there are thousands of health 
supplements, herbs, potions, and lotions used by the 
public regularly to treat their health problems [7]. Each 
year, in the United States alone, 7,000 to 9,000 people 
die as a result of a medication error. The total cost of 
looking after patients with medication-associated errors 
exceeds $40 billion each year [8]. The underlined 
causes are many – distractions, distortion, illegible 
writing, over/under dosing, SALAD, wrong metric 
measures, error induced kidney/liver dysfunction, 
wrong duration, use of abbreviations, supplement 
overload, wrong indication or direction, negligence, 
prescribing high risk medications etc [9-13]. The cost 
of medication errors worldwide has been estimated as 
US$42 billion/year [14, 15]. Doctors in US incorrectly 
prescribe antibiotics in nearly a third of cases. Study 
finds more than half of US population receives 
prescription annually and estimates ‘inappropriate’ 
prescriptions in doctor’s office setting at up to 30% 
[16]. NHS medication errors raise fears thousands 
could be dying because of 237 million mistakes every 
Year, some 237 million errors are made annually [17]. 
In India, studies done in Uttarakhand and Karnataka 
have documented ME rate to be as high as 25.7% and 
15.34%, respectively, in hospitalized patients. 
 
Nurse/Patient Ratio 
Despite progress in the healthcare industry toward 
achieving goals, nurse managers and administrators 
working on hospital units continue to struggle with 
knowing what constitutes the right number and quality 
of nurses matched to patients' needs to achieve clinical 
outcome targets. Consider that in 2016, 62.2% of the 
country's 2.6 million nurses worked in hospitals with a 
median pay of $68,450 per year [18]. With salaries 
making up nearly half of U.S. hospitals' expenses and 
nursing comprising about 30% of salaries, effective 
management of nursing resources, including staffing, is 
imperative for meeting financial outcomes. Higher 
nurse staffing and richer skill mix are associated with 
improved patient outcomes [19]. In addition, nurses 
provide up to 80% of primary healthcare. Thus, 
dissatisfaction with the nursing care may indicate poor 
healthcare quality and decreases the achievement of 
standards [20]. 
 
Length of Physician Consultation 
Primary care-driven health systems are effective at 
reducing disease, mortality and promoting a more 
equitable distribution of health worldwide. As the 
global population increases, the demand for primary 
care is also growing in both economically developed, 
low-income, middle-income countries. This is leading 
to an array of different consultation lengths, with 
concerns among primary care physicians worldwide 
about the impact of shorter consultations [21, 22]. 
Average consultation length is also used in the primary 
care monitoring tool as an outcome indicator [23]. 
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Consultation length is affected by the number of topics 
discussed with the patient; Consultation length often 
varies from one country to another and is determined 
by both patient's and doctor's characteristics; can be 
attributed to GP, patient and practice characteristics. 
While Deveugele et al. found that a longer consultation 
length was linked to females and older age. Howie et 
al. further discuss the issue of less attention being 
given to psychosocial issues in consultations [24, 
25].In USA the average consultation length has 
increased steadily to over 20 min [26], more than 15 
min in Canada [27] and less than 15 minutes in 
Australia [28]. Comparing this, terrible found in 
Hongkong and Afghanistan (around 3 min), in China 
and India (2 min) and less than 1 min in Bangladesh 
[29- 33]. 
 
High WTC 
Waiting is a common phenomenon in the doctor's 
waiting room. High number of patients, shortage of 
staff and aging equipment are among the factors 
contributing to a lengthy waiting time. At the 
emergency department (ED), prolonged wait times 
have been found to be associated with increased 
morbidity and mortality, and decreased patient 
satisfaction [34]. Although delays in care delivery are 
common—and unpleasant—occurrences in both public 
and private health care systems, there are few reliable 
data with which to determine the prevalence, degree, or 
nature of the problem. Patient waiting time in hospital 
emergency to receive the first treatment step was 66 
min in Australia [35], 45 min in USA [36], 50 min Iran 
[37] and 64 min Turkey [38]. According to SETS, care 
to be initiated in life-threatening emergencies 
(receiving immediate care), urgent conditions (to be 
seen within 20 minutes) [39]. 
 
Shortage of Physicians 
The world health organization predicts that the world 
needs an additional 10 million health care workers by 
2030 [40]. Between 2000 and 2030, the number of 
people in the United States over the age of 65 was 
expected to double. This elderly population makes 
twice as many physician visits as those under 65 [41]. 
More hospital staff along with physicians will be 
required with population growth. Interestingly, South 
Asian countries are lack of hospitals comparing to that. 
Nearly 86% of all the medical visit in India are made 
by rurales with majority still travelling more than 100 
km to avail health care facility of which 70-80% is 
born out of pocket landing them in poverty. 
Government succeeded in generating infrastructures in 
urban area but fail to do so in rural, sustaining 70% of 
Indian population [42]. However, The Times of India 
claims healthy doctor-patient ratio, 1:921 [43, 44], 
which is much fewer reported in Nepal (2.28 doctors, 
nurses, and midwives per 1000 population) [45], worst 
in rural Bangladesh (1.1 for 10000 people) [46]. 
 
Shortage of Hospital Supply 
Drug shortages have become all too common and 
affect all aspects of the health care delivery system. 
The increased number of drug shortages has had a 
negative impact on patient care as well as costly 
financial implications. Shortages of critical drugs such 
as chemotherapy agents, analgesics, injectable 
nutritional supplements, anesthetics, anti-infectives, 
and cardiovascular agents are common [47-50]. The 
impact of drug shortages is multifaceted, with over 
50% of health care practitioners believing that 
shortages have influenced practice and resulted in 
inferior patient care [51]. A Canadian study relayed 
anesthesiologists’ opinion that drug shortages were 
responsible for prolonged recovery times, delayed 
surgical procedure scheduling, and increased recovery 
cost. Nearly half of them (49%) felt shortages were the 
impetus for the administration of inferior anesthetics. 
Drug shortages often impact vulnerable populations 
including cancer patients or neonates, for whom few, if 
any, equivalent alternatives exist; shortages may result 
in clinical complications, as exemplified by selenium 
shortages. Drug shortages may also force practitioners 
to prescribe infrequently used medications and 
concentrations, which can lead to medication errors as 
demonstrated with prior fentanyl shortages. Drug 
shortages have also impacted life outside of patient 
care; for example, a planned execution in Oklahoma 
was delayed due to a drug shortage [52]. 
 
Quality Reporting by Hospital Staffs 
IRSs are and will continue to be an important influence 
on improving patient safety. However, they are not the 
panacea that many believe them to be. They have 
several limitations that should be considered. Most of 
these limitations stem from inherent biases of voluntary 
reporting systems. These limitations include: i) IRS 
can’t be used to measure safety (error rates); ii) IRS 
can’t be used to compare organizations; iii) IRS can’t 
be used to measure changes over time; iv) IRS generate 
too many reports; v) IRS often don’t generate in-depth 
analyses or result in strong interventions to reduce risk; 
vi) IRS are associated with costs. IRS do offer 
significant value; their value is found in the following: 
i) IRS can be used to identify local system hazards; ii) 
IRS can be used to aggregate experiences for 
uncommon conditions; iii) IRS can be used to share 
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lessons within and across organizations; iv) IRS can be 
used to increase patient safety culture. Moving 
forward, several strategies are suggested to maximize 
their value: i) make reporting easier; ii) make reporting 
meaningful to the reporter; iii) make the measure of 
success system changes, rather than events reported; 
iv) prioritize which events to report and investigate, 
report and investigate them well; v) convene with 
diverse stakeholders to enhance the value of IRS [53-
57]. 
 
Access to Healthcare 
According to the National Rural Hospital Association, 
“Currently one in three rural hospitals is in financial 
risk. At the current rate of closure, 25% of all rural 
hospitals will close within less than a decade in USA.” 
[58]A relatively similar situation found in China. 
Chinese patients often choose to directly access higher 
level hospitals, thus bypassing primary care facilities. 
As a result, higher level hospitals are overcrowded, 
while primary care facilities remain underutilized [59]. 
Conversely, poor housing condition, unsafe drinking 
water, lack of sanitation, use of biomass fuels, 
exposure to environmental odds as a part of the 
livelihood among the marginal population group often 
increase the risk of numerous health problems in India. 
12% critically ill patients remain untreated in the less 
developed villages[60]. According to WHO, 
5.9 million children under 5 years of age died in 2015, 
with a global under-five mortality rate of 42.5 per 1000 
live births. Levels of child mortality are higher in 
developing countries. Moreover, leading causes of 
child death in the post-neonatal period were 
pneumonia, diarrhea, injuries and malaria [61]. 
 
Hospital Acquired Sepsis 
Astonishingly, it seems that healthcare access and 
HCV prevalence are related in Pakistan; it is estimated 
that 70% of new HCV infections in Pakistan are 
attributed to routine medical procedures. Particularly 
concerning are infections caused by contaminated 
syringes, which are so prevalent in the healthcare 
settings. Villages are gripped by fear; no one knew 
whose life would be taken next by the deadly virus 
[62]. Nosocomial infections, otherwise known as 
hospital-acquired infections, are those infections 
acquired in hospital or healthcare service unit that first 
appear 48 h or more after hospital admission or within 
30 days after discharge following in patient care. HAP 
is the second most common nosocomial infection, and 
is the most common hospital infection leading to death 
in critically ill patients[63]. European acute care 
hospitals estimated the prevalence of healthcare-
associated infections to be 6%; of these, UTI was the 
third most common infection (19%). Based on this, the 
annual health burden of hospitalized patients with UTI 
was estimated to be 81.2 disability-adjusted life years 
per 100 000 individuals in the general population [64]. 
Healthcare-associated infections occur in both adult 
and pediatric patients. Bloodstream infections, 
followed by pneumonia and urinary tract infections are 
the most infections in children, urinary tract infections 
are the most common healthcare – associated infections 
in adults [65] 
 
Availability of Essential Drugs 
Worldwide, many countries have developed a list of 
essential medicines for children to improve prescribing. 
The WHO recommends that each country evaluate and 
adapt the list in order to create a list of essential 
medicines that is appropriate for its own environment. 
Specialty drugs are administered to less than 1% to 2% 
of the US population, yet they account for 38% of US 
prescription drug costs. By 2018, US specialty drug 
costs are expected to account for 50% of all US 
prescription drug costs [66]. In China, access to 
essential medicines for children is hampered by low 
availability. WHO has estimated that at least one-third 
of the world’s population does not have regular access 
to essential medicines [67]. Among Asia pacific 
countries, Korea was a country where more medicines 
were available than other countries [68]. A survey of 
the availability and price of 32 medicines for chronic 
diseases in six low- and middle-income countries 
(Bangladesh, Brazil, Malawi, Nepal, Pakistan and Sri 
Lanka) concluded that improvement of governance and 
management efficiency, and assessing local supply 
options, may improve availability of essential drugs. 
Prices could be reduced by improving purchasing 
efficiency, eliminating taxes and regulating mark-ups 
[69].In Canada, there is no list or central source of 
information related to safety, efficacy and tolerability 
of medication forms and formulations for children [70] 
and we cannot think of its existence in south Asian 
countries.  
 
High Prices of Drugs and Health Services 
Retail prescription drug spending in the US has been 
estimated at over US$340 billion annually, with 
projected growth to nearly US$600 billion by 2025, 
accounting for more than 10% of total healthcare 
spending in the US [71, 72]. High costs of new drugs 
and price increases for existing products have brought 
criticism and political interest in the drug pricing 
debate over rising drug prices as well as cost 
effectiveness and affordability [73-76]. Drug price 
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transparency has been argued as a potential solution to 
improve affordability within the US and abroad as it 
would improve the negotiating position for purchasers 
around the world [77]. According to a March 2017 
Bloomberg article, “in the U.S., $15 of every $100 
spent on brand-name drugs goes to middlemen…[and] 
the largest share, about $8, goes to benefit managers” 
[78]. Patients are the central figures in any healthcare 
system, and although they are often the victim of 
misaligned incentives, they also bear some 
responsibility for rising costs. Typically, patients are 
motivated to spend as little as possible out of pocket. 
India is the world's largest democracy, with an 
independent media and strong civil society. However, 
India ranks 130 on 2018 out of 189 countries HDI [79]. 
Poor households spent nearly 15% of their monthly 
income on healthcare in India [60]. 
 
Justified Use of Biotech Products 
Biologic agents, which are produced or derived from a 
living organism, are the most rapidly growing class of 
specialty drugs, and hold promise to revolutionize the 
management of a range of chronic medical conditions 
[80, 81]. The challenge, however, is reconciling the 
potential therapeutic benefit with the high cost of these 
agents. Specialty drugs contribute significantly to the 
inpatient diagnosis-related group payment system, 
often with unproved benefits over less-expensive 
therapies. These medications often may be more 
appropriate for initiation in the ambulatory setting, 
after the mechanism of payment for continued therapy 
has been established. As healthcare costs rise and 
reimbursements decrease, healthcare organization 
leadership and clinical providers must collaborate to 
provide high-value healthcare. Medications are a key 
driver of the increasing cost of healthcare, largely as a 
result of the proliferation of expensive specialty drugs, 
including biologic agents. Loosely defined based on 
their high costs, the need for special handling 
protocols, and close patient monitoring, specialty drugs 
are projected to account for 50% of the total medical 
expenditure by 2019 [82].  
 
Antibiotic Resistance  
Antibiotic treatment is one of the main approaches of 
modern medicine which is used to combat infections. 
The “golden era” of antibiotics ranged from the 1930s 
to 1960s which gave rise to many antibiotics [83]. In 
2018, GLASS reveals widespread occurrence of 
antibiotic resistance among 500 000 people with 
suspected bacterial infections across 22 countries. The 
most commonly reported resistant bacteria were 
Escherichia coli, Klebsiella pneumoniae, 
Staphylococcus aureus, and Streptococcus 
pneumoniae, followed by Salmonellaspp. “Some of the 
world’s most common – and potentially most 
dangerous – infections are proving drug-resistant,” –as 
stated by the director of WHO’s Antimicrobial 
Resistance Secretariat [83]. AMR poses a serious 
global threat of growing concern to human, animal, and 
environment health. This is due to the emergence, 
spread, and persistence of MDR bacteria or 
“superbugs.” MDR bacteria exist across the animal, 
human, and environment triangle or niche and there is 
interlinked sharing of these pathogens in this triad. The 
plausible causes of “the global resistome” or AMR 
include excessive use of antibiotics in animals (food, 
pets, aquatic) and humans, antibiotics sold over-the-
counter, increased international travel, poor 
sanitation/hygiene, and release of nonmetabolized 
antibiotics or their residues into the environment 
through manure/feces. These factors contribute to 
genetic selection pressure for the emergence of MDR 
bacterial infections in the community. Recently, the 
global consumption of antimicrobials in livestock has 
indicated the hotspots of antibiotics use across the 
continents that will have economic and public health 
impacts in the years to come. In food animals, 
antibiotics are commonly used in cattle, chicken, and 
pigs and it is projected that in 2030 such use will 
increase up to 67% in the most populated countries of 
the world. Furthermore, as many antibiotics are often 
inappropriately prescribed, a more personalized 
approach based on precise diagnosis tools will ensure 
that proper treatments can be promptly applied leading 
to more targeted and effective therapies. However, in 
more general terms, also the overall use and release of 
antibiotics in the environment needs to be better 
controlled [84-87]. 
 
Unnecessary Emergency Hospitalizations 
As concern grows in most countries over increasing 
health care costs, more attention is focused on reducing 
waste and unnecessary services. Reducing avoidable 
emergency department (ED) visits is an important 
health system goal. Around15% of ED visits end in 
inpatient admission [88, 89]. A significant number of 
'avoidable' ED visits reported by National Hospital 
Ambulatory Medical Care Survey from 2005 to 2011 
for mental health and dental conditions, where the ED 
is not fully equipped to treat [90]. In the US, the 
Centers for Medicare & Medicaid Services has 
implemented the first financial penalties on hospitals 
for excessive readmissions. Attention likely will be 
increasingly directed to all hospitalizations because 
readmissions represent only approximately 9% of 
International Journal of Health and Clinical Research, 2018;1(2):14-26                e-ISSN: 2590-3241, p-ISSN: 2590-325X                         
                                                             
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________ 
Mohiuddin                    International Journal of Health and Clinical Research, 2018; 1(2):14-26 
www.ijhcr.com                              
        19 
 
hospital admissions, and to avoidable ED visits 
because of the expense of providing care in this setting 
and its tendency to lead to unscheduled hospital 
admissions [91]. Because some visits are preventable, 
they may indicate poor care management, inadequate 
access to care, or poor choices on the part of patients. 
ED visits for conditions that are preventable or 
treatable with appropriate primary care lower health 
system efficiency and raise costs. An estimated 13% to 
27% of ED visits in the United States could be 
managed in physician offices, clinics, and urgent care 
centers, saving $4.4 billion annually [92-94]. 
 
Poor Health Diagnosis 
Both clinicians and patients rely on an accurate 
diagnostic process to identify the correct illness and 
craft a treatment plan. Achieving improved diagnostic 
accuracy also fulfills organizational fiscal, safety, and 
legal objectives. ‘Improving Diagnosis in Health Care’, 
report by Institute of Medicine in the USA concluded 
that most people will likely experience a diagnostic 
error in their lifetime [95]. Every nine minutes, a 
patient in a U.S. hospital dies because a diagnosis was 
wrong or delayed -- resulting in 80,000 deaths a year 
[96]. Terms such as overdiagnosis, underdiagnosis and 
undiagnosed are now frequently used, but their 
relationship to diagnostic error remains undefined [97]. 
Some research suggests that 40% of people in the 
vegetative state are misdiagnosed [98]. Because the 
clinical features of FD overlap with those of other 
disorders, errors and delays in diagnosis are common 
[99]. Despite being an extensively studied condition, 
the causes of ADHD remain poorly understood and 
substantial in children, controversy exists regarding its 
correct diagnosis [100]. In a retrospective analysis of 
clinical trials, 63% of deceased patients who were 
clinically diagnosed with AD while alive were found to 
have AD with other pathology [101]. The rate of 
misdiagnosis of patients with bipolar receiving 
outpatient treatment was quite high and they often 
received a misdiagnosis of depression [102]. Laryngeal 
edema has been associated with a mortality rate of 12–
40%, and in many undiagnosed cases, family history 
and recurrent skin and abdominal attacks since 
childhood could have informed the correct diagnosis 
[103]. 
 
Wrong Dispensing 
Dispensing errors occur in clinical and community 
pharmacy and commonly involve supply of the wrong 
drug, the wrong strength and the wrong form of 
medication [104, 105]. They occur at an average rate of 
4 in 250 prescriptions (1.6%) in pharmacies in the 
United States [106], and incidences up to 45% have 
been reported in different pharmacy settings [107]. A 
study in the Netherlands showed that 41% of all 
medication incidents in community pharmacies related 
to information technology, were about choosing the 
wrong drug. One third of incidents were associated 
with confusion of similar drug names and nearly half 
were associated with drug strength confusion [108]. 
Drug strength confusion can happen when two 
strengths of the same drug look alike, e.g. 3.75 mg and 
0.375 mg pramipexole [109]. Drug name and strength 
confusion are serious issues as they are preventable 
errors with potential detrimental impact on clinical 
practice and patient safety [110, 111]. 
 
Lack of Therapeutic Guideline Implementation 
Research indicates that clinical guidelines are often not 
applied. The success of theirimplementation depends 
on the consideration of a variety of barriers and the use 
of adequate strategies to overcome them. Despite the 
growing number of guidelines, their use in practice is 
frequently reported as being unpredictable, often slow 
and complex. It is estimated that about 30%–40% of 
patients receive treatment that is not based on scientific 
evidence, and 20%–25% receive treatments that are 
either not needed or potentially harmful [112,113]. 
Guideline adaptation has been defined as a systematic 
approach to modify and contextualize evidence-based 
guidelines to suit implementation in the local 
healthcare system. The process provides an opportunity 
to systematically consider transferability of 
recommendations across different settings, including 
variation in needs, values, costs, and availability of 
resources [114]. In India, clinical guidelines, also 
called standard treatment guidelines (STGs), are 
developed at the national and state levels and by a wide 
range of agencies. However, the quality of these 
guidelines is uncertain [115]. 
 
Poor Vaccination 
Of the nearly 10 million children who die each year 
before reaching their fifth birthday, WHO (World 
Health Organization) estimates that 2.5 million die 
from diseases that could be prevented with currently 
available or new vaccines [116]. However, in the 
United States it is estimated that 40,000–80,000 people 
die annually from VPDs, while hundreds of thousands 
more are hospitalized. The majority of cases and 99% 
of the deaths from VPDs are in older adults [117]. Yet, 
people continue to challenge the evidence and refuse 
vaccinations in many parts of the world. Vaccine 
hesitancy is the refusal of people to take vaccines or a 
delay in vaccine acceptance despite vaccination offers 
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from health authorities. This behavioral phenomenon is 
context- and vaccine-specific. HL is independently 
associated with several undesirable health outcomes, 
including poorer overall health status, hospitalization, 
mortality, and healthcare costs [118]. The Philippine 
dengue vaccination is the only mass dengue 
vaccination to date with more than 800,000 individuals 
vaccinated. Vaccination controversy due to perceived 
increased risk of serious dengue illness and death with 
the media associating the vaccine program to politics 
and corruption has caused low vaccine acceptability 
[119].Olive Healthcare was found to be manufacturing 
Enclomiphene (Estrogen receptor antagonist), a drug 
that is approved neither in India nor elsewhere [120]. 
Point is the same company supplied rancid Vitamin A 
capsules in Bangladesh which caused sickness 
(experiencing vomiting sensation and feeling unwell) 
in children of Chittagong, Cox’s Bazaar and 
Lakhimpur among other places of Bangladesh, back in 
2013 [121]. 
 
Pharmacists Role 
Medication errors are common in community 
pharmacies. Safety culture is considered a factor for 
medication safety but has not been measured in this 
setting. Both the discovery and reporting of medication 
errors can be improved by creating an environment 
where consultation about medication regimes are 
promoted between members of a network and with 
pharmacists. Understanding the safety culture of 
community pharmacies can help identify areas of 
strength and those that require improvement [122]. 
Standardized patient safety course should be 
considered in the curriculum for junior pharmacy 
students to improve their attitude toward patient safety. 
The World Health Organization (WHO) has also 
introduced an inclusive patient safety curriculum [123]. 
With the shifting role of community pharmacists 
towards patient education and counselling, they are 
well-positioned to conduct a post-discharge home visit 
which could prevent or solve drug-related problems 
[124].Close attention to patient safety associates with 
lowered incidences of adverse events in hospitals. 
Pharmacists are well positioned to facilitate the in-
patient care and discharge process by performing 
medication reconciliation, identifying patients with 
poor health literacy or non-adherence, and providing 
tailored discharge counselling [125]. Both the ACCP 
and ASHP have identified CPs as tools for pharmacists 
to provide cost-effective patient care plans, integrate 
pharmaceutical services, institutional culture, and 
partake leadership position in the development and 
implementation of the multifaceted pharmaceutical 
care [126]. Pharmacists have the unique education and 
training to identify MNA events early, as well as 
developing strategies to mitigate or resolve MNA 
related issues [126-130]. Pharmacists are not alone in 
their quest for patient safety and quality care. Still their 
role is significant in patient-care and safety 
measurement.  
 
Conclusion 
The expectation of the health care system is better care 
for patients, care that is standards-based and outcomes-
driven. This expectation is founded on the dual 
principle that every patient deserves to be safe and 
every patient deserves optimal medication therapy. 
Community pharmacists most frequently initiated 
practical issues, but explored patients’ medication 
beliefs less adequately. Inadequate patient counselling 
during the transition is a contributing factor. They must 
adapt their communication to address the wide variety 
of patients’ drug-related problems during these home 
visits and achieve patient-centered communication. It 
imparts increased patients’ satisfaction, better recall of 
information and improved health outcomes and 
requires active participation of both the pharmacist and 
the patient. Patients should be encouraged to express 
their needs and concerns regarding their medication, 
which pharmacists should address to support patients in 
making informed decisions. It is important to discuss 
patient experiences, beliefs and adherence issues pro-
actively, since not all patients might express these 
issues themselves. In pharmaceutical treatments, a 
unique pattern of social network in each healthcare 
setting can steer behaviors within organizations 
towards risk reduction in such environments. Gaining 
insight in the communication during these home visits 
could be valuable for optimizing these visits; and 
consequently, to improve patient safety at readmission 
to primary care. 
 
Abbreviations: Institute for HealthCare 
Consumerism's (IHC); Institute of Medicine (IOM); 
Incident Reporting Systems (IRS); Third Next 
available Appointment (TNA); Wait Time to 
Consultation (WTC); Sound-Alike/Look-Alike Drugs 
(SALAD); Swiss Emergency Triage Scale (SETS); 
Hepatitis C virus (HCV); Hospital-acquired pneumonia 
(HAP); Human Development Index HDI); Global 
Antimicrobial Surveillance System (GLASS); 
Antimicrobial Resistance (AMR); Multidrug-Resistant 
(MDR); Emergency Department (ED); Fabry disease 
(FD); Attention deficit hyperactivity disorder (ADHD); 
Alzheimer’s disease (AD); Vaccine-Preventable 
Diseases (VPDs); Health literacy (HL); American 
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Society of Health-System Pharmacists (ASHP); 
Clinical Pathways (CPs); Medication Non-Adherence 
(MNA). 
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